Updated: January 25, 2026
Drizalma Sprinkle Shortage Update: What Patients Need to Know in 2026
Author
Peter Daggett

Summarize with AI
The Drizalma Sprinkle shortage of 2023–2024 is resolved, but patients still face availability challenges. Here's what you need to know for 2026.
If you or someone you care for takes Drizalma Sprinkle (duloxetine delayed-release sprinkle capsules), you've probably heard about its shortage history and may be wondering about the current situation. Here is a clear, updated picture of Drizalma Sprinkle availability as of 2026 — what happened, where things stand now, and what to do if you still can't find it.
Is Drizalma Sprinkle Currently in Shortage in 2026?
The short answer: the formal shortage has been resolved. As of early 2026, Drizalma Sprinkle is not listed on the FDA or ASHP shortage databases. Sun Pharmaceutical Industries — the sole manufacturer of this formulation — relaunched production in mid-2024 and supply has been gradually rebuilding since then.
However, "not in formal shortage" does not mean it's universally available. Because Drizalma Sprinkle is a single-source, brand-name-only product with no FDA-approved generic equivalent, its availability still varies significantly by pharmacy, region, and dosage strength. Some patients continue to have difficulty finding their specific strength in stock locally.
Timeline: What Happened with Drizalma Sprinkle Shortages
- 2023: Sun Pharma, the only manufacturer of Drizalma Sprinkle, reported manufacturing disruptions. ASHP officially listed Drizalma Sprinkle as in shortage. Standard generic duloxetine capsules were not affected.
- Early 2024: Shortage continued. Patients relying on the sprinkle formulation faced difficulty obtaining prescriptions, particularly for children and patients with swallowing difficulties.
- Mid-2024: Sun Pharma relaunched Drizalma Sprinkle production. ASHP updated the shortage listing to reflect improving supply. Availability in 20 mg, 30 mg, 40 mg, and 60 mg strengths began to recover.
- Late 2024: Two separate voluntary recalls affected certain lots of GENERIC duloxetine delayed-release capsules (from other manufacturers) due to NDMA contamination concerns. These recalls did not directly affect Drizalma Sprinkle, but caused additional market confusion.
- Early 2025–2026: Formal shortage resolved. Drizalma Sprinkle generally available but with intermittent localized gaps, especially in less common strengths.
Why Does the Shortage Risk Remain?
The fundamental vulnerability hasn't changed: Drizalma Sprinkle is a single-source product. Sun Pharma is the only company that manufactures it. There is currently no FDA-approved generic sprinkle-capsule formulation of duloxetine. This means:
- Any production issue at Sun Pharma's facility could immediately impact supply
- There is no competing manufacturer to fill the gap
- Regional distribution gaps can create temporary localized shortages even during normal production
What Patients Are Currently Experiencing
In early 2026, most patients who need Drizalma Sprinkle can find it — but it often requires some searching. Patients on 60 mg typically have an easier time. Those on 20 mg or 40 mg (less common strengths) may find that not all pharmacies routinely stock those doses. Patients in rural areas or smaller communities may have fewer pharmacy options available to them.
What Should You Do Right Now?
- Use medfinder to locate stock: medfinder calls pharmacies near you to identify which ones have your specific medication and dosage currently available.
- Refill early: Request refills 7–10 days before you run out so you have time to locate stock if your usual pharmacy is temporarily out.
- Request a 90-day supply: Ask your prescriber to write a 90-day prescription so you have a larger buffer. This reduces how often you need to search for stock.
- Talk to your prescriber about a backup plan: Given the single-source nature of Drizalma Sprinkle, it's wise to have a conversation about what you would do if it became unavailable again. Know your options in advance.
- Never stop abruptly: If you cannot locate Drizalma Sprinkle, do not stop taking your medication without guidance. Duloxetine discontinuation can cause withdrawal symptoms including dizziness, nausea, and "brain zaps." Contact your prescriber immediately.
Key Takeaway for 2026
The formal Drizalma Sprinkle shortage is over, but its single-source status means vigilance is still warranted. Plan ahead, refill early, and don't wait until you're completely out of medication to start your search. For step-by-step guidance on locating it, read our article on how to find Drizalma Sprinkle in stock near you.
Frequently Asked Questions
As of early 2026, Drizalma Sprinkle is not listed on the FDA or ASHP drug shortage databases. The shortage that occurred in 2023–2024 when Sun Pharma had manufacturing disruptions has been resolved following the relaunch of production in mid-2024.
The NDMA (N-nitrosodimethylamine) contamination recalls in late 2024 affected certain lots of generic duloxetine delayed-release capsules from other manufacturers — not Drizalma Sprinkle itself. Drizalma Sprinkle is manufactured by Sun Pharma and was not part of those specific recalls.
Sun Pharmaceutical Industries — the sole manufacturer of Drizalma Sprinkle — experienced manufacturing disruptions in 2023, resulting in reduced supply. Because no other manufacturer makes this specific sprinkle formulation, the disruption created a direct nationwide shortage with no alternative source.
Drizalma Sprinkle is available in 20 mg, 30 mg, 40 mg, and 60 mg delayed-release sprinkle capsules. All four strengths were affected by the 2023–2024 shortage and have been relaunched. However, 20 mg and 40 mg are stocked less widely than 30 mg and 60 mg.
Don't stop your medication without talking to your doctor first, as abrupt discontinuation of duloxetine can cause withdrawal symptoms. Use medfinder to search a wider area, ask about mail-order options, or ask your pharmacist about a special order. Your doctor can also discuss whether a temporary alternative is appropriate.
Medfinder Editorial Standards
Medfinder's mission is to ensure every patient gets access to the medications they need. We are committed to providing trustworthy, evidence-based information to help you make informed health decisions.
Read our editorial standardsPatients searching for Drizalma Sprinkle also looked for:
More about Drizalma Sprinkle
31,238 have already found their meds with Medfinder.
Start your search today.





